secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dare Bioscience, Inc. (DARE)
CIK:        0001401914
Form:       8-K
Filed at:   2023-07-21T23:59:59+00:00
Accession:  0001401914-23-000042
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Daré Bioscience receives Nasdaq deficiency notice for bid price below $1.00; has until Jan 16, 2024 to regain compliance
--------------------------------------------------------------------------------

- Received Nasdaq letter on July 19, 2023, for failing Minimum Bid Price Requirement over 30 consecutive business days.
- Has 180 calendar days (until Jan 16, 2024) to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not, may be eligible for additional 180-day period if meeting other listing standards.
- Cannot assure compliance; considering options including reverse stock split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401914/000140191423000042/0001401914-23-000042-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401914/000140191423000042/dare-20230719.htm
  HTML page:      https://secwatch.observer/filing/0001401914-23-000042

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer